Short and Ultra-short-pulse ND: YAG 1064nm Lasers (Omer Smart and Omer Premium) for Stasis Dermatitis
Recruiting now · Not applicable
Conditions studied: Stasis Dermatitis
In brief
This study tests two types of lasers (ND YAG 1064 short and ultra-short pulses) to treat hyperchromic skin lesions secondary to venous hypertension (stasis dermatitis)
Key facts
- Study ID
- NCT06980961
- Run by
- Science Valley Research Institute
- People needed
- 20
- Starts
- 2025-05-20
- Expected to finish
- 2026-12-01
- Last updated by the study team
- 2025-05-20
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Women or men aged 18 to 89 years with stasis dermatitis secondary to venous hypertension
- Agreement with the terms of the survey and signing of the informed consent form
- Availability to make the necessary appointments for treatment and follow-up
- Provide consent to avoid pregnancy during treatment
- Have primary venous hypertension already treated (treatment of varicose veins of the lower limbs) by any of the available techniques
You may not qualify if…
- Men and women with CEAP 2 to 6, low mobility, no stasis dermatitis.
- Peripheral arterial disease.
- History of known allergy to the drugs used in this study
- Presence of other types of dermatitis in the lower extremities, such as allergic stasis eczema.
- Presence of comorbidities (such as diabetes mellitus, heart failure, respiratory failure, hypertension, hypothyroidism, or hyperthyroidism), pregnancy, breastfeeding, pulmonary hypertension, deep vein thrombosis (DVT), family history of DVT, known hypercoagulable states or thrombophilia, asthma, and migraine.
- Anyone who does not agree with any of the search terms.
Where it is running
- Clinica Ramacciotti — Santo André, São Paulo, Brazil (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.